Clinomics Europe at the 6th ACTC: „Liquid Biopsy and Precision Oncology: Where do we stand now?” meeting
We are thrilled to announce that our Senior Researcher, Dávid Kis, PhD, will present a poster at the 6th Advances in Circulating Tumor Cells: „Liquid Biopsy and Precision Oncology: Where do we stand now?” meeting on the beautiful Greek island of Skiathos between 20 – 23 of September.
Join us at the conference, where Dr. Kis will share insights on cutting-edge CTC research. Stay at the forefront of liquid biopsy and precision oncology, and don’t miss out on this hot topic!
Poster Title: CTC Quantification and Molecular Characterization by Digital PCR: Advancing Liquid Biopsy
Conference Details: https://www.erasmus.gr/microsites/1261
Enter PDACatch, a novel assay developed to detect circulating tumor DNA methylation signatures with greater sensitivity and accuracy.
Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction.
Singlera technologies 2: Early detection of residual molecular disease in colorectal cancer through circulating tumor DNA methylation
This study sought to answer the question of whether longitudinal changes in ctDNA methylation are effective in monitoring disease progression from molecular residual disease to recurrence.